enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Patients see first savings from Biden’s drug price push, as ...

   www.aol.com/finance/patients-see-first-savings...

   Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010. The ...

3. Medicare caps seniors drug expenses: What you need to know - AOL

   www.aol.com/news/medicare-caps-seniors-drug...

   Five cancer drugs − Revlimid, Pomalyst, Imbruvica, Jakafi, ... The discounts will range from 38% to 79% when the negotiated prices take effect in 2026. The bargaining will save Medicare $6 ...

4. Medicare announces weight-loss drugs, including Ozempic ... - AOL

   www.aol.com/news/medicare-announces-15-drugs...

   Pomalyst, a chemotherapy drug. Ibrance, a breast cancer drug. Ofev, for idiopathic pulmonary fibrosis. ... The new prices for those drugs are set to take effect in 2026.

5. Pomalidomide - Wikipedia

   en.wikipedia.org/wiki/Pomalidomide

   Pomalidomide, sold under the brand names Pomalyst and Imnovid, [7] [8] is an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma. [ 7 ] Pomalidomide was approved for medical use in the United States in February 2013, [ 10 ] and in the European Union in August 2013. [ 8 ]

6. Ozempic and Wegovy selected for next round of Medicare drug ...

   www.aol.com/ozempic-wegovy-selected-next-round...

   Pomalyst, treats multiple myeloma, AIDS-related Kaposi sarcoma. Ibrance, treats breast cancer. ... The list price for Ozempic is nearly $1,000 for a four-week supply, while Wegovy’s list price ...

7. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   homepage.aol.com/news

   Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

8. Medicare targets popular weight loss drugs Ozempic, Wegovy ...

   www.aol.com/news/medicare-targets-popular-weight...

   Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.

9. Was President Biden correct in saying Medicare Part D will ...

   www.aol.com/president-biden-correct-saying...

   KFF found that for the five drugs with the highest per capita Part D expenditures in 2021 used by more than 10,000 Part D enrollees — Revlimid, Pomalyst, Imbruvica, Jakafi and Ibrance, all ...